These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 31301073)
1. Preactivation of β-catenin in osteoblasts improves the osteoanabolic effect of PTH in type 1 diabetic mice. Chen S; Yang L; He S; Yang J; Liu D; Bao Q; Qin H; Du W; Zhong X; Chen C; Zong Z J Cell Physiol; 2020 Feb; 235(2):1480-1493. PubMed ID: 31301073 [TBL] [Abstract][Full Text] [Related]
2. N-cadherin restrains PTH activation of Lrp6/β-catenin signaling and osteoanabolic action. Revollo L; Kading J; Jeong SY; Li J; Salazar V; Mbalaviele G; Civitelli R J Bone Miner Res; 2015 Feb; 30(2):274-85. PubMed ID: 25088803 [TBL] [Abstract][Full Text] [Related]
3. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain. Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436 [TBL] [Abstract][Full Text] [Related]
4. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH. Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180 [TBL] [Abstract][Full Text] [Related]
5. Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival. Motyl KJ; McCauley LK; McCabe LR J Cell Physiol; 2012 Apr; 227(4):1326-34. PubMed ID: 21604269 [TBL] [Abstract][Full Text] [Related]
6. Tmem119 is involved in bone anabolic effects of PTH through enhanced osteoblastic bone formation in mice. Kawao N; Matsumura D; Yamada A; Okumoto K; Ohira T; Mizukami Y; Hashimoto D; Kaji H Bone; 2024 Apr; 181():117040. PubMed ID: 38316336 [TBL] [Abstract][Full Text] [Related]
7. The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics. Lombardi G; Di Somma C; Rubino M; Faggiano A; Vuolo L; Guerra E; Contaldi P; Savastano S; Colao A J Endocrinol Invest; 2011 Jul; 34(7 Suppl):18-22. PubMed ID: 21985975 [TBL] [Abstract][Full Text] [Related]
8. Normal epidermal growth factor receptor signaling is dispensable for bone anabolic effects of parathyroid hormone. Schneider MR; Dahlhoff M; Andrukhova O; Grill J; Glösmann M; Schüler C; Weber K; Wolf E; Erben RG Bone; 2012 Jan; 50(1):237-44. PubMed ID: 22056328 [TBL] [Abstract][Full Text] [Related]
10. Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin. Bonnet N; Conway SJ; Ferrari SL Proc Natl Acad Sci U S A; 2012 Sep; 109(37):15048-53. PubMed ID: 22927401 [TBL] [Abstract][Full Text] [Related]
11. Adult-Onset Deletion of β-Catenin in (10kb)Dmp1-Expressing Cells Prevents Intermittent PTH-Induced Bone Gain. Kedlaya R; Kang KS; Hong JM; Bettagere V; Lim KE; Horan D; Divieti-Pajevic P; Robling AG Endocrinology; 2016 Aug; 157(8):3047-57. PubMed ID: 27253995 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of type 1 diabetes mellitus and subsequent osteoblastic β-catenin activation on trabecular and cortical bone in a mouse model. Chen S; Liu D; He S; Yang L; Bao Q; Qin H; Liu H; Zhao Y; Zong Z Exp Mol Med; 2018 Dec; 50(12):1-14. PubMed ID: 30518745 [TBL] [Abstract][Full Text] [Related]
13. Interaction between p21-activated kinase 4 and β-catenin as a novel pathway for PTH-dependent osteoblast activation. Shen C; Oh HR; Park YR; Chen JH; Park BH; Park JH J Cell Physiol; 2024 Jun; 239(6):e31245. PubMed ID: 38497504 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans. Aslan D; Andersen MD; Gede LB; de Franca TK; Jørgensen SR; Schwarz P; Jørgensen NR Scand J Clin Lab Invest; 2012 Feb; 72(1):14-22. PubMed ID: 22085136 [TBL] [Abstract][Full Text] [Related]
15. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice. Saidak Z; Le Henaff C; Azzi S; Marty C; Marie PJ J Endocrinol; 2014 Oct; 223(1):25-33. PubMed ID: 25056116 [TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone regulates osteoblast differentiation in a Wnt/β-catenin-dependent manner. Tian Y; Xu Y; Fu Q; He M Mol Cell Biochem; 2011 Sep; 355(1-2):211-6. PubMed ID: 21533763 [TBL] [Abstract][Full Text] [Related]
17. Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy. Sinha P; Aarnisalo P; Chubb R; Poulton IJ; Guo J; Nachtrab G; Kimura T; Swami S; Saeed H; Chen M; Weinstein LS; Schipani E; Sims NA; Kronenberg HM; Wu JY J Biol Chem; 2016 Jan; 291(4):1631-1642. PubMed ID: 26598522 [TBL] [Abstract][Full Text] [Related]
18. Osteoblastic monocyte chemoattractant protein-1 (MCP-1) mediation of parathyroid hormone's anabolic actions in bone implicates TGF-β signaling. Siddiqui JA; Le Henaff C; Johnson J; He Z; Rifkin DB; Partridge NC Bone; 2021 Feb; 143():115762. PubMed ID: 33212319 [TBL] [Abstract][Full Text] [Related]
19. Over-expression of TIMP-1 in osteoblasts increases the anabolic response to PTH. Merciris D; Schiltz C; Legoupil N; Marty-Morieux C; de Vernejoul MC; Geoffroy V Bone; 2007 Jan; 40(1):75-83. PubMed ID: 16949899 [TBL] [Abstract][Full Text] [Related]
20. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo. Walker EC; Poulton IJ; McGregor NE; Ho PW; Allan EH; Quach JM; Martin TJ; Sims NA J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]